preloader

COPY OF PRESS RELEASE/ EXPLANATORY NOTE

  F.No. 8(30)/2000-DP/NPPA-Div.-II
National Pharmaceutical Pricing Authority
Ministry of Chemicals & Fertilizers
Government of India

2E/21, Jhandewalan Extension, Link Road,
New Delhi-110 055 Dated : 11th December, 2000.

Explanatory Note

 

The National Pharmaceutical Pricing Authority has revised/fixed the prices of 124 formulation packs on December 8, 2000. The prices have been fixed for the first time in the case of 21 formulation packs.  In the case of 3 packs, the price have been increased ranging from 7.78% to 26.68%.  In the case of 100 packs, the prices have been revised downwards and decrease ranges from 2.74% to 81.84%.

Of the 124 formulation packs, ceiling prices (exclusive of excise duty and local taxes) have been fixed in respect of 77 packs. The non-ceiling prices (inclusive of excise duty but exclusive of local taxes) have been fixed in respect of the remaining 47 packs.  The prices have been fixed/revised in accordance with the provisions of the Drugs Price Control Order (DPCO), 1995 and as per the established criteria and guidelines. A copy of the statement showing the existing (where available) and revised prices is enclosed herewith. The Notifications are available on the NPPA web-site www. nppaindia.com.

The formulations for which prices have been revised/fixed are Asprin based formulations used as Analgesic/Cardiovascular drug; Pseudoephedrine based formulations used as Anti-tussive; Cefadroxyl, Cefazolin, Cefatoxime, Cloxacillin based formulations used as a broad spectrum Antibiotic; Chloroquine Phosphate based Injection used in the treatment of Malaria; Pentazocine based formulations used as Analgesic; and Tonic containing liver extract and vitamins. The revision in prices has occurred due to change in the bulk drug prices.

The prices fixed/revised would become effective within 15 days from the date of notification in the official gazette or the receipt of the order of the NPPA in this behalf, as per Para 14(1) of DPCO, 1995.  Necessary revised price list is to be issued by the manufacturers/importers required under sub paragraph (3) of paragraph 14 of the DPCO, 1995.  Accordingly, as per the provision, the revised price list in Form-V of the DPCO is to be furnished by the concerned manufacturer to the government and NPPA, State Drug Control Authorities and distributors, wholesalers and retailers or any other agent.

The manufacturers are also required to work out the pro-rata prices of different pack sizes as the case may be in terms of S.O. No. 83 (E) date 27.01.98.

 

(L. M. Kaushal)
Deputy Director

Encl. : As above

Last Page Updated: 17-01-2019